FDA inspection
North China Pharmaceutical Huasheng Co., LTD: FDA inspection ending Aug 10, 2018
FDA inspection 1064484 · Voluntary Action Indicated (VAI) · Shijiazhuang
Key facts
| Inspection ID | 1064484 |
|---|---|
| Firm | North China Pharmaceutical Huasheng Co., LTD |
| FEI number | 3003001488 |
| Address | No. 8 Yangzi Road, Shijiazhuang, Economic & Tech. Development Zone |
| City | Shijiazhuang |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Aug 10, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data